Cravath Swaine & Moore is representing Viatris in the transaction. Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Idorsia Ltd (SIX: IDIA) announced they have entered...
You must be a Standard 1 Year member to access this content.
Carey advised Viatris on the deal. Viatris announced the sale of the distribution and intellectual property rights of a leading portfolio of products in Latin America. Aspen...
You must be a Standard 1 Year member to access this content.
Saraf and Partners acted for Viatris on the deal, and Willkie Farr & Gallagher acted for Cooper Consumer Health Global healthcare leader Viatris, (formerly known as...
You must be a Standard 1 Year member to access this content.
Cravath represented Viatris in the transaction, while White & Case advised Famy Life Sciences. Famy Life Sciences, a market-leading drug development platform, announced its entry into...
You must be a Standard 1 Year member to access this content.
Cooley advised Oyster Point Pharma on the deal, while Cravath represented Viatris. Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, announced its definitive agreement to be acquired...
You must be a Standard 1 Year member to access this content.
Cravath and Saraf and Partners represented Viatris in the transaction while Shardul Amarchand Mangaldas & Co and Goodwin Procter advised Biocon Biologics. Viatris Inc. reached a...
You must be a Standard 1 Year member to access this content.
